140 related articles for article (PubMed ID: 35462659)
1. Prognostic Roles of ZNF703 and SMAD4 Expression in Patients with Papillary Thyroid Cancer and Association with Nodal Metastasis.
Mohamed AH; Harb OA; Shorbagy SE; Balata R; Amin MF; Abd-Elaziz O
Indian J Surg Oncol; 2022 Mar; 13(1):169-177. PubMed ID: 35462659
[TBL] [Abstract][Full Text] [Related]
2. ZNF703 is Overexpressed in Papillary Thyroid Carcinoma Tissues and Mediates K1 Cell Proliferation.
Yang X; Liu G; Zang L; Li D; Yu F; Xiang X; Li W
Pathol Oncol Res; 2020 Jan; 26(1):355-364. PubMed ID: 30361900
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
4. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
5. Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
Zeng Z; Li K; Wang X; Ouyang S; Zhang Z; Liu Z; Sun J; Ye X; Kang W; Yu J
World J Surg Oncol; 2021 Jul; 19(1):208. PubMed ID: 34253203
[TBL] [Abstract][Full Text] [Related]
6. Value of Ultrasound Combined with Immunohistochemistry Evaluation of Central Lymph Node Metastasis for the Prognosis of Papillary Thyroid Carcinoma.
Yao X; Meng Y; Guo R; Lu G; Jin L; Wang Y; Yang D
Cancer Manag Res; 2020; 12():8787-8799. PubMed ID: 33061575
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography.
Xue T; Liu C; Liu JJ; Hao YH; Shi YP; Zhang XX; Zhang YJ; Zhao YF; Liu LP
Front Oncol; 2021; 11():794399. PubMed ID: 35004319
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
Li X; Zhang H; Zhou Y; Cheng R
World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
[TBL] [Abstract][Full Text] [Related]
9. Integrating BRAF
Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.
Zhao YZ; He NA; Ye XJ; Jin F; Li MX; Jiang X
Front Endocrinol (Lausanne); 2022; 13():880911. PubMed ID: 35733781
[TBL] [Abstract][Full Text] [Related]
11. The Clinicopathological Features of Papillary Thyroid Carcinoma Patients with Positive Hepatitis B Surface Antigen.
Zhong Z; Yuan J; Chen X; Chen Z; Du J; Chen Z; Kuang J; Cong S; Li J; Wu Z
Oncol Res Treat; 2020; 43(1-2):27-33. PubMed ID: 31722345
[TBL] [Abstract][Full Text] [Related]
12. A prediction model incorporating the BRAF
Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
[TBL] [Abstract][Full Text] [Related]
13. Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with
Li GY; Tan HL; Chen P; Hu HY; Liu M; Ou-Yang DJ; Khushbu RA; Pun D; Li JD; Zhang ZP; Yang Q; Huang P; Chang S
Cancer Manag Res; 2020; 12():3371-3378. PubMed ID: 32494201
[TBL] [Abstract][Full Text] [Related]
14. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.
Zhou B; Wei L; Qin J
Asian J Surg; 2021 Nov; 44(11):1357-1362. PubMed ID: 33715963
[TBL] [Abstract][Full Text] [Related]
15. Predicting factors of central lymph node metastasis and BRAF
Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
[TBL] [Abstract][Full Text] [Related]
16. Fasting serum glucose and lymph node metastasis in non-diabetic PTC patients: a 10-Year multicenter retrospective study.
Liu Y; Gong J; Huang Y; Xing S; Chen L; Yi T; Wang Z; Lv Y
J Cancer; 2022; 13(8):2673-2682. PubMed ID: 35711846
[No Abstract] [Full Text] [Related]
17. Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma.
Yan Y; Wang Y; Liu N; Duan Y; Chen X; Ye B; Yang R; Zhang W; Wang X
Eur J Surg Oncol; 2021 Jul; 47(7):1727-1733. PubMed ID: 33632590
[TBL] [Abstract][Full Text] [Related]
18. Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.
Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Shin DH; Lee BJ
J Surg Oncol; 2013 Jun; 107(7):777-82. PubMed ID: 23640873
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
20. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients.
Wang K; Li H; Zhao J; Yao J; Lu Y; Dong J; Bai J; Liao L
Front Cell Dev Biol; 2022; 10():1001954. PubMed ID: 36568979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
